Abbott Laboratories Aktie
| 123,64USD | -1,06USD | -0,85% |
WKN: 850103 / ISIN: US0028241000
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 109 000 | 113 000 | 115 000 | 114 000 | 114 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,32 | 0,38 | 0,38 | 0,35 | 0,37 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 20 441 | 24 239 | 25 224 | 22 670 | 23 656 |
| Summe Anlagevermögen | 52 107 | 50 957 | 49 214 | 50 544 | 57 758 |
| Summe Aktiva | 72 548 | 75 196 | 74 438 | 73 214 | 81 414 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 39 545 | 39 172 | 37 533 | 34 387 | 33 513 |
| Summe Eigenkapital | 33 003 | 36 024 | 36 905 | 38 827 | 47 901 |
| Summe Passiva | 72 548 | 75 196 | 74 438 | 73 214 | 81 414 |
Adresse
| 100 Abbott Park Road, 60064-6400 Abbott Park | |
| Telefon | +1 (224) 667-6100 |
| Internet | http://www.abbott.com |
Management
|
Alison Davies
Treasurer & Vice President |
|
Celestino Jacinto Dos Anjos
Controller-Pharmaceuticals Division |
|
Claire L. Babineaux-Fontenot
Independent Director |
|
Daniel Gesua Sive Salvadori
Executive Vice President-Nutritional Products |
|
Daniel J. Starks
Independent Director |
|
Darren W. McDew
Independent Director |
|
Elizabeth Cushman
Senior Vice President-Legal |
|
Gene Huang
Chief Economist & Vice President |
|
Jim Leffelman
Manager-Expense Reporting |
|
John A. McCoy
Vice President-Finance & Controller |
|
John G. Stratton
Independent Director |
|
Karen Wong Chayavirabood
Regional Director-Asia |
|
Kathryn S. Collins
Vice President-Commercial Legal Operations |
|
Lisa D. Earnhardt
Group President-Medical Devices & Executive VP |
|
Mary K. Moreland
Executive Vice President-Human Resources |
|
Melissa Brotz
Senior VP-Global Marketing & External Affairs |
|
Michael F. Roman
Independent Director |
|
Michael G. O'Grady
Independent Director |
|
Michelle A. Kumbier
Independent Director |
|
Nancy McKinstry
Lead Independent Director |
|
Paola Gonzalez
Independent Director |
|
Philip P. Boudreau
Chief Financial Officer & Executive VP-Finance |
|
Randel William Woodgrift
Senior Vice President-Cardiac Rhythm Management |
|
Robert B. Ford
Chairman, President & Chief Executive Officer |
|
Robert J. Alpern
Independent Director |
|
Sabina Ewing
Chief Information Officer |
|
Sally E. Blount
Independent Director |
|
Scott J. House
Senior VP-Regulatory & Engineering Services |
|
Scott Leinenweber
Senior VP-Licensing, Acquisitions & Ventures |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.